CN1241591C - Taiyi liver protection capsule and its preparing method - Google Patents
Taiyi liver protection capsule and its preparing method Download PDFInfo
- Publication number
- CN1241591C CN1241591C CNB031376932A CN03137693A CN1241591C CN 1241591 C CN1241591 C CN 1241591C CN B031376932 A CNB031376932 A CN B031376932A CN 03137693 A CN03137693 A CN 03137693A CN 1241591 C CN1241591 C CN 1241591C
- Authority
- CN
- China
- Prior art keywords
- grams
- hepatitis
- root
- capsule
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a taiyi liver protection capsule and a preparation method thereof, and the taiyi liver protection capsule belongs to a pure Chinese herb compound capsule preparation for treating hepatitis B and hepatitis B virus infection. A prescription is prepared from heterophylly falsestarwort root, raw milkvetch root, large-flowered purslane, raw rhubarb, oldenlandia, red sage root, hawthorn fruit, baical skullcap root, bupleurum root, twotoothed achyranthes root, rhizoma, black ant and ganoderma. The rhubarb, the ganoderma, the rhizoma and the black ants in the prescription are pulverized into fine powder; the rest medicinal ingredients are decocted thrice by adding water; decoction liquid is merged and filtered; filter liquid is concentrated into ointment; the ointment is mixed with the fine powder and manufactured into granules; the present invention is obtained by that the granules is dried, pulverized and encapsulated. Content in the capsule is brownish yellow powder with fragrance and mildly bitter flavor, and 0.45 gram of the brownish yellow powder is filled in each capsule. The present invention is orally admitted thrice a day, and 4 to 6 capsules are swallowed with warm water after one hour after meal each time. Drinking is avoided during the period of taking medicine. The present invention is suitable for treating antiviral immunity regulation and control of PCR positive patients with dasanyang and xiaosanyang which are infected by the hepatitis B viruses. The total effective rate of the conversion of hepatitis B virus carriers is 78.7%, and the present invention has a favorable effect on treating ASC.
Description
The present invention is the Chinese medicine compound capsule preparations of treatment hepatitis B and hepatitis B virus infection.Prescription is composed as follows: Radix Pseudostellariae 10-20 gram, Radix Astragali 30 grams, Herba Scutellariae Barbatae 15-30 gram, Radix Et Rhizoma Rhei 5 grams, Herba Hedyotidis Diffusae 30 grams, Radix Salviae Miltiorrhizae 12 grams, Fructus Crataegi 15 grams, Radix Scutellariae 12 grams, Radix Bupleuri 6 grams, Radix Achyranthis Bidentatae 6 grams, Rhizoma Paridis 15 grams, Formica fusca 6 grams, Ganoderma 6 grams.
Radix Et Rhizoma Rhei, Ganoderma, Rhizoma Paridis, Formica fusca in above 13 flavors are ground into fine powder, and nine flavors such as all the other Radixs Astragali decoct with water three times, and 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction filtered, and filtrate is condensed into cream.Condensed cream is mixed with above-mentioned fine powder, make granule, oven dry is pulverized, and is promptly encapsulated.Tolerant within the capsule is pale brown toner end, gas perfume (or spice), and mildly bitter flavor is adorned 0.45 gram for every.
Asymptomatic HbsAg carrier (ASC) due to hepatitis B virus (HBV) infects and existing disease patient are similar to the incubative pathogen and the struggle between vital QI and pathogen of traditional Chinese medical science traditional theory, so the hepatitis B virus stage of carrying is called " evil poison dormancy ", existing disease patient is called " evil poison is a disease ".
In the HBV dormancy body, mainly be because of immune function of human body low.Should focus on the raising immunologic function to this, impose antiviral therapy in good time.Improve immunologic function, should follow the pathogenesis of the weakened body resistance wet silt of the traditional Chinese medical science, the malicious impairing the liver of volt, fill blood based on flat, hold concurrently with removing dampness invigorate blood circulation, eliminating fire and detoxication.The patient bitter taste poor appetite, weak agitation, ALT occurred and increased this moment, illustrate that human body immune function is activated, and by originally HBV reactionless transferring to being responded, was that treatment effectively shows, and facts have proved to help late result.
HbsAg was positive more than half a year, was to be the Chronic HBV carrier.Should be based on adjusting the activation body's immunological function to this class patient, the hepatocellular apoptosis process that quickening is infected and integrated by HBV is blocked it and is changed and the effect of undergoing mutation to fibrosis.The traditional Chinese medical science fills blood to put down, removing dampness is invigorated blood circulation, dialectical the executing of the method for eliminating fire and detoxication controlled.As adopt Ganoderma, the short guided cell virus apoptosis of Formica fusca, block the possibility that causes the hepatocyte sudden change.
By the existing disease patient that HBV causes, comprise 3 types of acute hepatitis b, hepatitis gravis and chronic hepatitiss.
The slight person of slow type hepatitis B, it is complete or be the low reaction state mostly to be body's immunity, and HBV continues to duplicate, make a small amount of hepatocyte and liver organization constantly impaired, clinically see that the ALT long time mild raises, HbeAg, HBV-DNA lasting masculin, the patient is with weak poor appetite, and the abdominal distention hypochondriac pain is a cardinal symptom.The dialectical heresy that belongs to is accumulate stagnation of liver-QI, asthenia of both the spleen and kidney, positive QI-insufficiency, anti-evil ineffective more.This moment exciting human healthy energy effectively, heresy of accumulateing in holder poison reach outward and clearly it.Radix Pseudostellariae, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Poria benefiting qi and raising yang such as Formica fusca, Radix Achyranthis Bidentatae, reinforcing kidney and strengthening resistance in addition in the prescription of the present invention.The continuous impaired symptom of moderate and severe patient hepatocyte and liver function is more obvious, dialectical genus dampness-heat in the liver and gallbladder, obstruction of collaterals by blood stasis, the hepatic and renal YIN deficiency.Treatment is started with from heat-clearing and toxic substances removing earlier, has both separated antibacterial, virus and endotoxic exogenous poison, can separate the poison of the endogenous of oxygen-derived free radicals and cytokine again, and then also can induce or promote the apoptosis integrated by HBV, blocks its mutagenic process.
The present invention is directed to hepatitis B the etiology and pathology of development takes place, full side's QI invigorating and do not help damp, heat clearing away and do not hinder healthy energy, anti-biography are subjected to and are beneficial to whole-course treatment.Comprehensive its function is flat to fill blood, removing dampness is invigorated blood circulation, eliminating fire and detoxication, adjustment immunity of organisms, suppresses hepatitis B virus duplication and quickens the apoptosis process of infected hepatocyte DNA.Be applicable to that " great three positive " of hepatitis B virus infection reaches the PCR positive patient antiviral immunity regulation and control treatment of " small three positive ".Clinical practice proves that it is 78.7% that hepatitis B virus carriers transforms total effective rate, and ASC is respond well to treatment.
This capsule is an oral formulations, 3 times on the one, one time 4～6,1 hour after meal warm water delivery service.Period in a medicine is given up alcohol.
Claims (1)
1. a Chinese medicinal capsule for the treatment of hepatitis B is characterized in that being made by the raw material of Chinese medicine combination of following weight: Radix Pseudostellariae 10-20 gram, Radix Astragali 30 grams, Herba Scutellariae Barbatae 15-30 gram, Radix Et Rhizoma Rhei 5 grams, Herba Hedyotidis Diffusae 30 grams, Radix Salviae Miltiorrhizae 12 grams, Fructus Crataegi 15 grams, Radix Scutellariae 12 grams, Radix Bupleuri 6 grams, Radix Achyranthis Bidentatae 6 grams, Rhizoma Paridis 15 grams, Formica fusca 6 grams, Ganoderma 6 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031376932A CN1241591C (en) | 2003-06-20 | 2003-06-20 | Taiyi liver protection capsule and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031376932A CN1241591C (en) | 2003-06-20 | 2003-06-20 | Taiyi liver protection capsule and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1457871A CN1457871A (en) | 2003-11-26 |
| CN1241591C true CN1241591C (en) | 2006-02-15 |
Family
ID=29430690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031376932A Expired - Fee Related CN1241591C (en) | 2003-06-20 | 2003-06-20 | Taiyi liver protection capsule and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1241591C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100460010C (en) * | 2005-05-29 | 2009-02-11 | 王福山 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
-
2003
- 2003-06-20 CN CNB031376932A patent/CN1241591C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1457871A (en) | 2003-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488850B (en) | Traditional Chinese medicinal composition for treating alcoholic fatty liver and preparation method thereof | |
| CN102178875A (en) | Traditional Chinese pill used for treating liver disease | |
| CN1304744A (en) | Chinese medicine for curing hepatitis B and cirrhosis ascites | |
| CN1178675C (en) | Toxin-discharging liver-fortifying medicine | |
| CN1145240A (en) | Medicinal compsn. for prevention of Aids virus and cancer | |
| CN104324259A (en) | Pharmaceutical composition for treating hepatitis B and preparation method of pharmaceutical composition | |
| CN1785357A (en) | Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method | |
| CN1060938C (en) | Chinese medicinal instant powder for treatment of B-hepatitis | |
| CN103041200A (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN1241591C (en) | Taiyi liver protection capsule and its preparing method | |
| CN101757408A (en) | Medicament for treating lupus erythematosus and preparation method thereof | |
| CN102671056B (en) | Chinese medicinal composition for treating hepatitis and preparation method thereof | |
| CN102091288A (en) | Chinese medicine preparation for treating fatty liver and preparation method thereof | |
| CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN101385842B (en) | Medicine for treating chronic hepatitis b and preparation method thereof | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN102949659A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN1471956A (en) | Replenishing bone marrow and generating blood granules and their preparing method | |
| CN104758827B (en) | A kind of composition of medicine for being used to treat acute viral hepatitis | |
| CN1943682A (en) | A Chinese traditional medicinal composition for treatment of hepatitis C | |
| CN114272349A (en) | Traditional Chinese medicine composition for tonifying spleen and nourishing liver and preparation method and application thereof | |
| CN102406906A (en) | Traditional Chinese medicine composition for treating acute hepatitis B | |
| CN1061885C (en) | Specific infusion for hepatitis B and producing process thereof | |
| CN1352979A (en) | Chinese medicine for replenishing vital energy and promoting blood circulation | |
| CN1375325A (en) | Composite medicine for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060215 Termination date: 20120620 |